Medco Research obtains summary judgment in securities fraud action
Clients Medco Research, Inc.
Jones Day represented Medco Research, Inc. in a securities fraud class action alleging that Medco misled investors concerning the prospects of FDA approval for a new drug. Summary judgment was granted in favor of Medco by the district court and affirmed on appeal by the Seventh Circuit.
Lasalle, et al. v. Medco Research, Inc., et al., No. 93-CIV-5381 (N.D. Ill.) aff'd, No. 96-2345 (7th Cir.)